Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis.
暂无分享,去创建一个
[1] S. Waikar,et al. Diagnosis, epidemiology and outcomes of acute kidney injury. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[2] J Concato,et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. , 2008, Kidney international.
[3] A. Garg,et al. Acute kidney injury: Better biomarkers and beyond. , 2008, Kidney international.
[4] A. Hirayama,et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[5] M. Okusa,et al. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[6] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[7] J. Kato,et al. Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: possibility of postoperative left ventricular remodeling effect. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[8] J. Kato,et al. Efficacy of Low-Dose Continuous Infusion of α-Human Atrial Natriuretic Peptide (hANP) During Cardiac Surgery , 2006 .
[9] T. Greene,et al. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[10] C. Edelstein,et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. , 2006, Kidney international.
[11] S. Nigwekar,et al. Atrial natriuretic peptide for preventing and treating acute renal failure , 2006 .
[12] M. Okusa,et al. Acute kidney injury associated with cardiac surgery. , 2005, Clinical journal of the American Society of Nephrology : CJASN.
[13] G. Herbison,et al. Interventions for protecting renal function in the perioperative period. , 2005, The Cochrane database of systematic reviews.
[14] M. Makuuchi,et al. Prevention of Renal Impairment by Continuous Infusion of Human Atrial Natriuretic Peptide after Liver Transplantation , 2005, Transplantation.
[15] S. Ricksten,et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial* , 2004, Critical care medicine.
[16] H. Matsuda,et al. Synthetic Human &agr;-Atrial Natriuretic Peptide Improves the Management of Postoperative Hypertension and Renal Dysfunction after the Repair of Abdominal Aortic Aneurysm , 2003 .
[17] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[18] D. vesely,et al. Natriuretic peptides and acute renal failure. , 2003, American journal of physiology. Renal physiology.
[19] S. Ricksten,et al. Long‐term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure , 2001, Acta anaesthesiologica Scandinavica.
[20] S. Chihara,et al. Effects of intraoperative administration of atrial natriuretic peptide. , 2000, The Annals of thoracic surgery.
[21] J. Lewis,et al. Atrial natriuretic factor in oliguric acute renal failure , 2000 .
[22] M. Shiono,et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. , 2000, The Annals of thoracic surgery.
[23] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[24] S. Ginzel,et al. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery--a randomized controlled trial. , 1999, Wiener klinische Wochenschrift.
[25] E. Bates,et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] U. Neumann,et al. Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled study. , 1997, Clinical transplantation.
[27] W. Forssmann,et al. URODILATIN (INN: ULARITIDE) AS A NEW DRUG FOR THE THERAPY OF ACUTE RENAL FAILURE FOLLOWING CARDIAC SURGERY , 1997, Clinical and experimental pharmacology & physiology.
[28] R. Lafayette,et al. Anaritide in Acute Tubular Necrosis , 1997 .
[29] M. Meyer,et al. Urodilatin (INN: Ularitide) Ein neues Peptid in der Intensivbehandlung des akuten Nierenversagens nach Lebertransplantation , 1996, Der Anaesthesist.
[30] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[31] B. Meiser,et al. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation. , 1995, European journal of medical research.
[32] J. Squifflet,et al. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation. , 1995, Clinical transplantation.
[33] T. Hedner,et al. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery , 1994, Intensive Care Medicine.
[34] R. Pichlmayr,et al. Urodilatin: a new approach for the treatment of therapy‐resistant acute renal failure after liver transplantation , 1994, European journal of clinical investigation.
[35] T. Hedner,et al. Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. , 1994, Journal of cardiothoracic and vascular anesthesia.
[36] R. Schrier,et al. Effects of atrial natriuretic peptide in clinical acute renal failure. , 1994, Kidney international.
[37] R. Hetzer,et al. Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients , 1992, The clinical investigator.
[38] C. Lang,et al. Atrial natriuretic factor improves renal function and lowers systolic blood pressure in renal allograft recipients treated with cyclosporin A. , 1992, Journal of hypertension.
[39] S. Falk,et al. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. , 1991, Kidney international.
[40] W. Mitch,et al. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. , 1991, Journal of the American Society of Nephrology : JASN.
[41] P. Kurnik,et al. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. , 1990, The Journal of laboratory and clinical medicine.
[42] J. Ketelslegers,et al. Atrial natriuretic factor: a protective role after acute renal ischemia? , 1990, Transplant international : official journal of the European Society for Organ Transplantation.
[43] T. Inagami,et al. Atrial natriuretic factor. , 1989, The Journal of biological chemistry.
[44] D. Roy. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. , 1986, The American journal of physiology.
[45] M. Shiono,et al. Efficacy of Continuous Low-Dose Human Atrial Natriuretic Peptide Given from the Beginning of Cardiopulmonary Bypass for Thoracic Aortic Surgery , 2006, Surgery Today.
[46] J. Sellgren,et al. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans , 2004, Intensive Care Medicine.
[47] H. Matsuda,et al. Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. , 2003, Journal of cardiovascular pharmacology.
[48] G. Chertow,et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[49] W. Forssmann,et al. Therapeutic use of the natriuretic peptide ularitide in acute renal failure. , 1999, Renal failure.
[50] A. Sugawara,et al. Atrial natriuretic peptide as a preload depressor in acute renal failure secondary to congestive heart failure. , 1998, Renal failure.
[51] R. Lafayette,et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. , 1997, The New England journal of medicine.
[52] H. Schlitt,et al. [Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation]. , 1996, Der Anaesthesist.